Kanvas Biosciences Announces $12 Million Pre-Series A to Accelerate Microbiome Drug Development
Cornell startup Kanvas Biosciences, founded by professor Iwijn De Vlaminck, Ph.D. alum Hao Shi, and Matthew Cheng, announced the company secured $12 Million Pre-Series A to accelerate microbiome drug development. Read more about Kanvas Biosciences Announces $12 Million Pre-Series A to Accelerate Microbiome Drug Development